Imparare a tradurre dagli esempi di traduzione forniti da contributi umani.
Da: Traduzione automatica
Suggerisci una traduzione migliore
Qualità:
Da traduttori professionisti, imprese, pagine web e archivi di traduzione disponibili gratuitamente al pubblico.
Ühes kolmest uuringust võrreldi ravimit ka latanoprostiga (samuti prostaglandiini analoog, mida kasutatakse glaukoomi raviks).
one of the three trials also included a comparison with latanoprost (another prostaglandin analogue used for glaucoma). .
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
lumigani võrreldi ka latanoprostiga (samuti glaukoomi raviks kasutatav prostaglandiini analoog) kuuekuulises uuringus, milles osales 269 patsienti.
it has also been compared with latanoprost (another prostaglandin analogue used in glaucoma) in a six-month study involving 269 patients.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
lumigani efektiivsust selle lisamisel ravile beetablokaatoriga võrreldi latanoprostiga veel ühes uuringus, milles 7 westferry circus, canary wharf, london e14 4hb, uk tel.
lumigan’ s effectiveness when added to beta-blocker treatment has also been compared with that of 7 westferry circus, canary wharf, london e14 4hb, uk tel.
Ultimo aggiornamento 2012-04-11
Frequenza di utilizzo: 2
Qualità:
duotravi keskmine silmasisest rõhku langetava toime samaväärsus võrreldes latanoprostiga 50 mikrogrammi/ ml + timolool 5 mg/ ml leidis kinnitust iga külastuse igal ajahetkel.
the non-inferiority of duotrav as compared to latanoprost 50 micrograms/ ml + timolol 5 mg/ ml in the mean iop reduction was demonstrated across all time-points at all visits.
Ultimo aggiornamento 2012-04-11
Frequenza di utilizzo: 2
Qualità:
konjunktiivi hüpereemia, ripsmekarvade vohamise ja silma sügelemise esinemissagedus oli võrreldes latanoprostiga statistiliselt märkimisväärselt kõrgem bimatoprostiga; kuid kõrvalnähtudest tingitud ravimi kasutamise katkestamise sagedus oli madal ning seal statistiliselt olulist erinevust kahe grupi vahel ei esinenud.
conjunctival hyperaemia, growth of eyelashes, and eye pruritus were statistically significantly higher with bimatoprost than with latanoprost, however, the discontinuation rates due to adverse events were low with no statistically significant difference.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
6 kuud kestnud kliinilise uuringu käigus lumigan’iga 0,3 mg/ml (mitmeannuseline formulatsioon) võrreldes latanoprostiga, ilmnes statistiliselt oluline hommikuse keskmise silmasisese rõhu vähenemine (-7,6 kuni -8,2 mmhg bimatoprosti kasutamisel võrreldes -6,0 kuni -7,2 mmhg latanoprosti kasutamisel) kõikidel visiitidel kogu uuringu vältel.
in a 6-month clinical study with lumigan 0.3 mg/ml (multi-dose formulation), versus latanoprost, a statistically superior reduction in morning mean iop (ranging from -7.6 to -8.2 mmhg for bimatoprost versus –6.0 to -7.2 mmhg for latanoprost) was observed at all visits throughout the study.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità: